Loading clinical trials...
Loading clinical trials...
The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Department of Anesthesiology and Operative Intensive Care Medicine Campus Virchow-Klinikum
Berlin, Germany
Start Date
January 1, 2021
Primary Completion Date
February 21, 2022
Completion Date
August 31, 2022
Last Updated
October 29, 2024
2,398
ACTUAL participants
Lead Sponsor
Charite University, Berlin, Germany
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232